Literature DB >> 19057892

Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

H Sato, T Abe, R Wakusawa, N Asai, H Kunikata, H Ohta, H Sonoda, Y Sato, K Nishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19057892     DOI： 10.1007/s00125-008-1229-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  9 in total

1.  Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin.

Authors:  Hikaru Sonoda; Hideki Ohta; Kazuhide Watanabe; Hiroshi Yamashita; Hiroshi Kimura; Yasufumi Sato
Journal:  Biochem Biophys Res Commun       Date:  2006-02-13       Impact factor: 3.575

Review 2.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

Authors:  J W Miller; A P Adamis; L P Aiello
Journal:  Diabetes Metab Rev       Date:  1997-03

3.  Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Hidetaka Noma; Hideki Mochizuki; Tatsuya Mimura; Tomohiro Ikeda; Sadao Hori
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

4.  Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.

Authors:  Nahoko Ogata; Maki Nishikawa; Tetsuya Nishimura; Yumiko Mitsuma; Miyo Matsumura
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

5.  Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.

Authors:  Kazuhide Watanabe; Yasuhiro Hasegawa; Hiroshi Yamashita; Kazue Shimizu; Yuanying Ding; Mayumi Abe; Hideki Ohta; Keiichi Imagawa; Kanji Hojo; Hideo Maki; Hikaru Sonoda; Yasufumi Sato
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.

Authors:  Ryosuke Wakusawa; Toshiaki Abe; Hajime Sato; Madoka Yoshida; Hiroshi Kunikata; Yasufumi Sato; Kohji Nishida
Journal:  Am J Ophthalmol       Date:  2008-05-16       Impact factor: 5.258

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.

Authors:  Jikui Shen; XiaoRu Yang; Wei-Hong Xiao; Sean F Hackett; Yasufumi Sato; Peter A Campochiaro
Journal:  FASEB J       Date:  2006-02-10       Impact factor: 5.191

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
  9 in total
  12 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

2.  Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.

Authors:  Zhanlong Shen; Hanna Seppänen; Tuuli Kauttu; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  J Interferon Cytokine Res       Date:  2013-05-07       Impact factor: 2.607

3.  Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery.

Authors:  Qizhi Wang; Xiangguo Tian; Chunqing Zhang; Qiangxiu Wang
Journal:  Med Oncol       Date:  2011-11-19       Impact factor: 3.064

Review 4.  Novel targets against retinal angiogenesis in diabetic retinopathy.

Authors:  Shuang Wang; James K Park; Elia J Duh
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 5.  The vasohibin family: a novel family for angiogenesis regulation.

Authors:  Yasufumi Sato
Journal:  J Biochem       Date:  2012-10-25       Impact factor: 3.387

6.  Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix.

Authors:  Chandra Shekhar Boosani; Yakkanti A Sudhakar
Journal:  Pharmaceuticals (Basel)       Date:  2011-12

7.  The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.

Authors:  Yoshifumi Takahashi; Yasushi Saga; Takahiro Koyanagi; Yuji Takei; Sizuo Machida; Akiyo Taneichi; Hiroaki Mizukami; Yasufumi Sato; Shigeki Matsubara; Hiroyuki Fujiwara
Journal:  Int J Oncol       Date:  2015-10-08       Impact factor: 5.650

Review 8.  The Vasohibin Family.

Authors:  Yasufumi Sato
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-05

9.  Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.

Authors:  Kaori Suenaga; Shuji Kitahara; Yasuhiro Suzuki; Miho Kobayashi; Sachiko Horie; Junichi Sugawara; Nobuo Yaegashi; Yasufumi Sato
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 10.  The roles of vasohibin and its family members: Beyond angiogenesis modulators.

Authors:  Hua Du; Jing Zhao; Ling Hai; Jing Wu; Hua Yi; Yonghong Shi
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.